Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of MicroRNA-155 on atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 4, 2015, Pages 796-803

  Wei, Yuanyuan ^a,b   Zhu, Mengyu ^a   Corbalán Campos, Judit ^a,b   Heyll, Kathrin ^a   Weber, Christian ^a,b,c   Schober, Andreas ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Munich Heart Alliance   (Germany)

Author keywords

atherosclerosis; macrophages; microRNAs

Indexed keywords

APOLIPOPROTEIN E; COLONY STIMULATING FACTOR 1; MICRORNA 155; PROTEIN BCL 6; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; BCL6 PROTEIN, MOUSE; CHOLESTEROL; COLONY STIMULATING FACTOR RECEPTOR; DNA BINDING PROTEIN; MICRORNA; MIRN155 MICRORNA, MOUSE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL AGING, CELL DEGENERATION AND CELL SURVIVAL; CELL DAMAGE; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; DOWN REGULATION; EFFEROCYTOSIS; EXPERIMENTAL ATHEROSCLEROSIS; GENE EXPRESSION; GENE INACTIVATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; UPREGULATION; ANIMAL; AORTA; AORTA DISEASE; ATHEROSCLEROSIS; BLOOD; BONE MARROW TRANSPLANTATION; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIPID DIET; MACROPHAGE; METABOLISM; NECROSIS; PATHOLOGY; SIGNAL TRANSDUCTION; TIME;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE, KNOCKOUT; MICRORNAS; NECROSIS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84929317018     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304723     Document Type: Article

References (47)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128. doi: 10.1016/S0140-6736(12)61728-0.
2. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17:1410-1422. doi: 10.1038/nm.2538.
3. Robbins CS, Hilgendorf I, Weber GF, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19:1166-1172. doi: 10.1038/nm.3258.
4. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254-257. doi: 10.1038/344254a0.
5. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 1985;41:665-676.
6. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol. 2006;18:39-48. doi: 10.1016/j. coi.2005.11.006.
7. Di Gregoli K, Johnson JL. Role of colony-stimulating factors in atherosclerosis. Curr Opin Lipidol. 2012;23:412-421. doi: 10.1097/ MOL.0b013e328357ca6e.
8. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36-46. doi: 10.1038/nri2675.
9. Gautier EL, Huby T, Witztum JL, Ouzilleau B, Miller ER, Saint-Charles F, Aucouturier P, Chapman MJ, Lesnik P. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation. 2009;119:1795-1804. doi: 10.1161/ CIRCULATIONAHA.108.806158.
10. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003;5:781-792. doi: 10.1038/ncb1035.
11. Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol. 2009;86:1089-1095. doi: 10.1189/jlb.0209115.
12. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12: 99-110. doi: 10.1038/nrg2936.
13. Carroll AP, Tooney PA, Cairns MJ. Context-specific microRNA function in developmental complexity. J Mol Cell Biol. 2013;5:73-84. doi: 10.1093/jmcb/mjt004.
14. Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, Wang S, Kiessling F, Olson EN, Weber C. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20:368-376. doi: 10.1038/nm.3487.
15. Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A. MicroRNA-126,-145, and-155: A therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol. 2013;33:449-454. doi: 10.1161/ATVBAHA.112.300279.
16. Wei Y, Schober A, Weber C. Pathogenic arterial remodeling: The good and bad of microRNAs. Am J Physiol Heart Circ Physiol. 2013;304: H1050-H1059. doi: 10.1152/ajpheart.00267.2012.
17. Wei Y, Nazari-Jahantigh M, Chan L, Zhu M, Heyll K, Corbalán-Campos J, Hartmann P, Thiemann A, Weber C, Schober A. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1-and microRNA-155-dependent pathway during atherosclerosis. Circulation. 2013;127:1609-1619. doi: 10.1161/CIRCULATIONAHA.112.000736.
18. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, Weber C, Schober A. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122:4190-4202. doi: 10.1172/JCI61716.
19. Du F, Yu F, Wang Y, Hui Y, Carnevale K, Fu M, Lu H, Fan D. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014;34:759-767. doi: 10.1161/ATVBAHA.113.302701.
20. Tian FJ, An LN, Wang GK, et al. Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Cardiovasc Res. 2014;103:100-110. doi: 10.1093/cvr/cvu070.
21. Donners MM, Wolfs IM, Stöger LJ, van der Vorst EP, Pöttgens CC, Heymans S, Schroen B, Gijbels MJ, de Winther MP. Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PLoS One. 2012;7:e35877. doi: 10.1371/journal. pone.0035877.
22. Randolph GJ. Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res. 2014;114:1757-1771. doi: 10.1161/ CIRCRESAHA.114.301174.
23. Lin J, Li H, Yang M, et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep. 2013;3:200-210. doi: 10.1016/j. celrep.2012.12.012.
24. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med. 2008;205:585-594. doi: 10.1084/jem.20072108.
25. Nikolic D, Calderon L, Du L, Post SR. SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. BMC Immunol. 2011;12:37. doi: 10.1186/1471-2172-12-37.
26. Bijkerk R, de Bruin RG, van Solingen C, Duijs JM, Kobayashi K, van der Veer EP, ten Dijke P, Rabelink TJ, Goumans MJ, van Zonneveld AJ. MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-β-induced endothelial to mesenchymal transition. Microrna. 2012;1:2-10.
27. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008;28:6773-6784. doi: 10.1128/MCB.00941-08.
28. Hashimoto D, Chow A, Noizat C, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792-804. doi: 10.1016/j. immuni.2013.04.004.
29. Jenkins SJ, Ruckerl D, Thomas GD, Hewitson JP, Duncan S, Brombacher F, Maizels RM, Hume DA, Allen JE. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med. 2013;210:2477-2491. doi: 10.1084/jem.20121999.
30. Murayama T, Yokode M, Kataoka H, Imabayashi T, Yoshida H, Sano H, Nishikawa S, Nishikawa S, Kita T. Intraperitoneal administration of antic-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. Circulation. 1999;99:1740-1746.
31. de Villiers WJ, Fraser IP, Hughes DA, Doyle AG, Gordon S. Macrophagecolony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med. 1994;180:705-709.
32. Nakaya M, Tanaka M, Okabe Y, Hanayama R, Nagata S. Opposite effects of rho family GTPases on engulfment of apoptotic cells by macrophages. J Biol Chem. 2006;281:8836-8842. doi: 10.1074/jbc.M510972200.
33. Pixley FJ, Xiong Y, Yu RY, Sahai EA, Stanley ER, Ye BH. BCL6 suppresses RhoA activity to alter macrophage morphology and motility. J Cell Sci. 2005;118(Pt 9):1873-1883. doi: 10.1242/jcs.02314.
34. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014;14:166-180. doi: 10.1038/nri3607.
35. Barish GD, Yu RT, Karunasiri MS, et al. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab. 2012;15:554-562. doi: 10.1016/j.cmet.2012.02.012.
36. Kellner-Weibel G, Geng YJ, Rothblat GH. Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane. Atherosclerosis. 1999;146:309-319.
37. Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, Thomas MJ, Hiltbold EM, Fessler MB, Parks JS. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res. 2010;51:3196-3206. doi: 10.1194/jlr. M006486.
38. Zhu X, Lee JY, Timmins JM, Brown JM, Boudyguina E, Mulya A, Gebre AK, Willingham MC, Hiltbold EM, Mishra N, Maeda N, Parks JS. Increased cellular free cholesterol in macrophage-specific Abca1 knockout mice enhances pro-inflammatory response of macrophages. J Biol Chem. 2008;283:22930-22941. doi: 10.1074/jbc.M801408200.
39. Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanfi M, Han S, Ishibashi M, Li R, Wang N, Tall AR. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation. 2008;118:1837-1847. doi: 10.1161/CIRCULATIONAHA.108.793869.
40. Sun Y, Ishibashi M, Seimon T, et al. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogenactivated protein kinase and induces cathepsin K. Circ Res. 2009;104: 455-465. doi: 10.1161/CIRCRESAHA.108.182568.
41. Fessler MB, Parks JS. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol. 2011;187:1529-1535. doi: 10.4049/jimmunol.1100253.
42. Quinn SR, Mangan NE, Caffrey BE, Gantier MP, Williams BR, Hertzog PJ, McCoy CE, O'Neill LA. The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10. J Biol Chem. 2014;289:4316-4325. doi: 10.1074/jbc.M113.522730.
43. Elton TS, Selemon H, Elton SM, Parinandi NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013;532:1-12. doi: 10.1016/j.gene.2012.12.009.
44. Dueck A, Eichner A, Sixt M, Meister G. A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation. FEBS Lett. 2014;588:632-640. doi: 10.1016/j.febslet.2014.01.009.
45. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009;31:220-231. doi: 10.1016/j. immuni.2009.06.024.
46. Feo F, Canuto RA, Torrielli MV, Garcea R, Dianzani MU. Effect of a cholesterol-rich diet on cholesterol content and phagocytic activity of rat macrophages. Agents Actions. 1976;6:135-142.
47. Dianzani MU, Torrielli MV, Canuto RA, Garcea R, Feo F. The influence of enrichment with cholesterol on the phagocytic activity of rat macrophages. J Pathol. 1976;118:193-199. doi: 10.1002/path.1711180402.